Accendra Health, Inc.
ACH
$1.12
$0.021.82%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.30% | -0.01% | 3.06% | -40.79% | -58.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.30% | -0.01% | 3.06% | -40.79% | -58.18% |
| Cost of Revenue | 2.19% | 3.65% | 5.22% | -53.61% | -70.36% |
| Gross Profit | -9.30% | -4.00% | 0.70% | -14.39% | -24.10% |
| SG&A Expenses | -3.38% | -1.31% | -1.37% | -15.89% | -25.95% |
| Depreciation & Amortization | 189.66% | 101.05% | 11.49% | -58.67% | -53.78% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.07% | 2.80% | 2.49% | -42.97% | -60.05% |
| Operating Income | -69.94% | -37.17% | 12.24% | 10.29% | 0.18% |
| Income Before Tax | 70.50% | 64.30% | 69.09% | -5,680.44% | -1,982.82% |
| Income Tax Expenses | -118.25% | -129.62% | -96.50% | 604.79% | 367.63% |
| Earnings from Continuing Operations | 73.56% | 69.12% | 70.72% | -38,899.91% | -4,665.08% |
| Earnings from Discontinued Operations | 75.59% | -3,865.85% | -8,250.43% | -1,819.14% | -2,230.96% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.88% | -195.84% | -203.47% | -2,647.63% | -2,734.35% |
| EBIT | -69.94% | -37.17% | 12.24% | 10.29% | 0.18% |
| EBITDA | -15.17% | -6.56% | 5.25% | -23.21% | -29.09% |
| EPS Basic | 74.91% | -195.20% | -202.54% | -2,642.66% | -2,724.61% |
| Normalized Basic EPS | -184.39% | -119.71% | 1.25% | 14.13% | 3.05% |
| EPS Diluted | 74.88% | -195.37% | -202.76% | -2,631.93% | -2,711.96% |
| Normalized Diluted EPS | -184.79% | -119.79% | 2.05% | 16.36% | 3.96% |
| Average Basic Shares Outstanding | -0.30% | -0.15% | 0.43% | 0.59% | 0.82% |
| Average Diluted Shares Outstanding | -0.75% | -0.60% | -0.02% | -0.34% | 0.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |